Biovie Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.20

-0.26 (-17.81%)

As of Mar 22, 10:59 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +2,331.7% upside

Low Target $17.82

Average Target $29.18

High Target $40.31

Current Price $1.20

Current
$1.20

Target
$29.18

$17.82 $29.18 avg $40.31

Scenario Analysis

Bear Case

$17.82

1,385.0%

Low target

Base Case

$29.18

+2,331.7%

Avg target

Bull Case

$40.31

+3,259.2%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$13.20

-90.9% from high

52-Week Low

$1.06

+13.2% from low

Target vs 52W High

$29.18

+121.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%